These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20729923)

  • 1. Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient.
    Dohm A; Hasenkamp J; Bertsch HP; Maas JH; Truemper L; Wulf G
    Bone Marrow Transplant; 2011 Jun; 46(6):899-900. PubMed ID: 20729923
    [No Abstract]   [Full Text] [Related]  

  • 2. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease.
    Sbano P; Rubegni P; De Aloe GB; Guidi S; Fimiani M
    Bone Marrow Transplant; 2004 Apr; 33(8):869-70. PubMed ID: 14743190
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
    Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease.
    Vakkila J; Thomson AW; Hovi L; Vettenranta K; Saarinen-Pihkala UM
    Bone Marrow Transplant; 2005 Mar; 35(5):501-7. PubMed ID: 15665841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
    Komanduri KV; Couriel D; Champlin RE
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
    Perotti C; Del Fante C; Viarengo G; Salvaneschi L
    Transfusion; 2004 Oct; 44(10):1531-2. PubMed ID: 15383028
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
    Sakashita K; Saito S; Yanagisawa R; Tanaka M; Yoshikawa K; Hirabayashi K; Tsukahara K; Motobayashi M; Nakazawa Y; Koike K
    Pediatr Blood Cancer; 2013 Nov; 60(11):E140-2. PubMed ID: 23788509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease.
    Chan GW; Foss FM; Klein AK; Sprague K; Miller KB
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):753-9. PubMed ID: 14677114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation.
    Kotani A; Hori T; Fujita T; Kambe N; Matsumura Y; Ishikawa T; Miyachi Y; Nagai K; Tanaka Y; Uchiyama T
    Bone Marrow Transplant; 2007 Mar; 39(6):373-5. PubMed ID: 17277792
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracorporeal photopheresis in chronic graft-versus-host disease.
    Foss FM; Gorgun G; Miller KB
    Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
    Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
    Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
    Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.